Industry Research Reports

Home > Reports > Medical Devices & Consumables > Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 95 Pages

Report ld: 3503578

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Atrial Septal Defect (ASD) Occluder was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Atrial Septal Defect (ASD) Occluder was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Atrial Septal Defect (ASD) Occluder was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Atrial Septal Defect (ASD) Occluder include Gore Medical, Abbott, Lepu Medical, Lifetech, Occlutech, MicroPort Group, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Atrial Septal Defect (ASD) Occluder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Atrial Septal Defect (ASD) Occluder by region & country, by Type, and by Application.

The Atrial Septal Defect (ASD) Occluder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrial Septal Defect (ASD) Occluder.

MARKET SEGMENTATION

By Company

Gore Medical
Abbott
Lepu Medical
Lifetech
Occlutech
MicroPort Group

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

16-32 mm Type
34-50 mm Type

Segment by Application

Children
Adult

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Atrial Septal Defect (ASD) Occluder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Atrial Septal Defect (ASD) Occluder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Atrial Septal Defect (ASD) Occluder in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Atrial Septal Defect (ASD) Occluder Product Introduction

1.2 Global Atrial Septal Defect (ASD) Occluder Market Size Forecast

1.2.1 Global Atrial Septal Defect (ASD) Occluder Sales Value (2020-2031)

1.2.2 Global Atrial Septal Defect (ASD) Occluder Sales Volume (2020-2031)

1.2.3 Global Atrial Septal Defect (ASD) Occluder Sales Price (2020-2031)

1.3 Atrial Septal Defect (ASD) Occluder Market Trends & Drivers

1.3.1 Atrial Septal Defect (ASD) Occluder Industry Trends

1.3.2 Atrial Septal Defect (ASD) Occluder Market Drivers & Opportunity

1.3.3 Atrial Septal Defect (ASD) Occluder Market Challenges

1.3.4 Atrial Septal Defect (ASD) Occluder Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Atrial Septal Defect (ASD) Occluder Players Revenue Ranking (2024)

2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Company (2020-2025)

2.3 Global Atrial Septal Defect (ASD) Occluder Players Sales Volume Ranking (2024)

2.4 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Company Players (2020-2025)

2.5 Global Atrial Septal Defect (ASD) Occluder Average Price by Company (2020-2025)

2.6 Key Manufacturers Atrial Septal Defect (ASD) Occluder Manufacturing Base and Headquarters

2.7 Key Manufacturers Atrial Septal Defect (ASD) Occluder Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Atrial Septal Defect (ASD) Occluder

2.9 Atrial Septal Defect (ASD) Occluder Market Competitive Analysis

2.9.1 Atrial Septal Defect (ASD) Occluder Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Atrial Septal Defect (ASD) Occluder Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrial Septal Defect (ASD) Occluder as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 16-32 mm Type

3.1.2 34-50 mm Type

3.2 Global Atrial Septal Defect (ASD) Occluder Sales Value by Type

3.2.1 Global Atrial Septal Defect (ASD) Occluder Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Atrial Septal Defect (ASD) Occluder Sales Value, by Type (2020-2031)

3.2.3 Global Atrial Septal Defect (ASD) Occluder Sales Value, by Type (%) (2020-2031)

3.3 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Type

3.3.1 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Atrial Septal Defect (ASD) Occluder Sales Volume, by Type (2020-2031)

3.3.3 Global Atrial Septal Defect (ASD) Occluder Sales Volume, by Type (%) (2020-2031)

3.4 Global Atrial Septal Defect (ASD) Occluder Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Children

4.1.2 Adult

4.2 Global Atrial Septal Defect (ASD) Occluder Sales Value by Application

4.2.1 Global Atrial Septal Defect (ASD) Occluder Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Atrial Septal Defect (ASD) Occluder Sales Value, by Application (2020-2031)

4.2.3 Global Atrial Septal Defect (ASD) Occluder Sales Value, by Application (%) (2020-2031)

4.3 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Application

4.3.1 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Atrial Septal Defect (ASD) Occluder Sales Volume, by Application (2020-2031)

4.3.3 Global Atrial Septal Defect (ASD) Occluder Sales Volume, by Application (%) (2020-2031)

4.4 Global Atrial Septal Defect (ASD) Occluder Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Atrial Septal Defect (ASD) Occluder Sales Value by Region

5.1.1 Global Atrial Septal Defect (ASD) Occluder Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (2020-2025)

5.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (2026-2031)

5.1.4 Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (%), (2020-2031)

5.2 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region

5.2.1 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (2020-2025)

5.2.3 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (2026-2031)

5.2.4 Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (%), (2020-2031)

5.3 Global Atrial Septal Defect (ASD) Occluder Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

5.4.2 North America Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

5.5.2 Europe Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

5.6.2 Asia Pacific Atrial Septal Defect (ASD) Occluder Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

5.7.2 South America Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

5.8.2 Middle East & Africa Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value

6.2.1 Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.2.2 Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.3.2 United States Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.4.2 Europe Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.5.2 China Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.5.3 China Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.6.2 Japan Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.7.2 South Korea Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.8.2 Southeast Asia Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Atrial Septal Defect (ASD) Occluder Sales Value, 2020-2031

6.9.2 India Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

6.9.3 India Atrial Septal Defect (ASD) Occluder Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Gore Medical

7.1.1 Gore Medical Company Information

7.1.2 Gore Medical Introduction and Business Overview

7.1.3 Gore Medical Atrial Septal Defect (ASD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Gore Medical Atrial Septal Defect (ASD) Occluder Product Offerings

7.1.5 Gore Medical Recent Development

7.2 Abbott

7.2.1 Abbott Company Information

7.2.2 Abbott Introduction and Business Overview

7.2.3 Abbott Atrial Septal Defect (ASD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Abbott Atrial Septal Defect (ASD) Occluder Product Offerings

7.2.5 Abbott Recent Development

7.3 Lepu Medical

7.3.1 Lepu Medical Company Information

7.3.2 Lepu Medical Introduction and Business Overview

7.3.3 Lepu Medical Atrial Septal Defect (ASD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Lepu Medical Atrial Septal Defect (ASD) Occluder Product Offerings

7.3.5 Lepu Medical Recent Development

7.4 Lifetech

7.4.1 Lifetech Company Information

7.4.2 Lifetech Introduction and Business Overview

7.4.3 Lifetech Atrial Septal Defect (ASD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Lifetech Atrial Septal Defect (ASD) Occluder Product Offerings

7.4.5 Lifetech Recent Development

7.5 Occlutech

7.5.1 Occlutech Company Information

7.5.2 Occlutech Introduction and Business Overview

7.5.3 Occlutech Atrial Septal Defect (ASD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Occlutech Atrial Septal Defect (ASD) Occluder Product Offerings

7.5.5 Occlutech Recent Development

7.6 MicroPort Group

7.6.1 MicroPort Group Company Information

7.6.2 MicroPort Group Introduction and Business Overview

7.6.3 MicroPort Group Atrial Septal Defect (ASD) Occluder Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 MicroPort Group Atrial Septal Defect (ASD) Occluder Product Offerings

7.6.5 MicroPort Group Recent Development

8 Industry Chain Analysis

8.1 Atrial Septal Defect (ASD) Occluder Industrial Chain

8.2 Atrial Septal Defect (ASD) Occluder Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Atrial Septal Defect (ASD) Occluder Sales Model

8.5.2 Sales Channel

8.5.3 Atrial Septal Defect (ASD) Occluder Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Atrial Septal Defect (ASD) Occluder Market Trends

Table 2. Atrial Septal Defect (ASD) Occluder Market Drivers & Opportunity

Table 3. Atrial Septal Defect (ASD) Occluder Market Challenges

Table 4. Atrial Septal Defect (ASD) Occluder Market Restraints

Table 5. Global Atrial Septal Defect (ASD) Occluder Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Company (2020-2025)

Table 7. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Atrial Septal Defect (ASD) Occluder Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Atrial Septal Defect (ASD) Occluder Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Atrial Septal Defect (ASD) Occluder Manufacturing Base and Headquarters

Table 11. Key Manufacturers Atrial Septal Defect (ASD) Occluder Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Atrial Septal Defect (ASD) Occluder

Table 13. Global Atrial Septal Defect (ASD) Occluder Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrial Septal Defect (ASD) Occluder as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Atrial Septal Defect (ASD) Occluder Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Atrial Septal Defect (ASD) Occluder Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Atrial Septal Defect (ASD) Occluder Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Value by Type (2020-2025)

Table 20. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Value by Type (2026-2031)

Table 21. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Atrial Septal Defect (ASD) Occluder Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Atrial Septal Defect (ASD) Occluder Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Atrial Septal Defect (ASD) Occluder Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Atrial Septal Defect (ASD) Occluder Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Atrial Septal Defect (ASD) Occluder Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Value by Application (2020-2025)

Table 32. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Value by Application (2026-2031)

Table 33. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Atrial Septal Defect (ASD) Occluder Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Atrial Septal Defect (ASD) Occluder Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Atrial Septal Defect (ASD) Occluder Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Atrial Septal Defect (ASD) Occluder Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (2020-2025) & (%)

Table 44. Global Atrial Septal Defect (ASD) Occluder Sales Value by Region (2026-2031) & (%)

Table 45. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (2020-2025) & (%)

Table 49. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Region (2026-2031) & (%)

Table 50. Global Atrial Septal Defect (ASD) Occluder Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Atrial Septal Defect (ASD) Occluder Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Volume, (2026-2031) & (K Units)

Table 57. Gore Medical Company Information

Table 58. Gore Medical Introduction and Business Overview

Table 59. Gore Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Gore Medical Atrial Septal Defect (ASD) Occluder Product Offerings

Table 61. Gore Medical Recent Development

Table 62. Abbott Company Information

Table 63. Abbott Introduction and Business Overview

Table 64. Abbott Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Abbott Atrial Septal Defect (ASD) Occluder Product Offerings

Table 66. Abbott Recent Development

Table 67. Lepu Medical Company Information

Table 68. Lepu Medical Introduction and Business Overview

Table 69. Lepu Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Lepu Medical Atrial Septal Defect (ASD) Occluder Product Offerings

Table 71. Lepu Medical Recent Development

Table 72. Lifetech Company Information

Table 73. Lifetech Introduction and Business Overview

Table 74. Lifetech Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Lifetech Atrial Septal Defect (ASD) Occluder Product Offerings

Table 76. Lifetech Recent Development

Table 77. Occlutech Company Information

Table 78. Occlutech Introduction and Business Overview

Table 79. Occlutech Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Occlutech Atrial Septal Defect (ASD) Occluder Product Offerings

Table 81. Occlutech Recent Development

Table 82. MicroPort Group Company Information

Table 83. MicroPort Group Introduction and Business Overview

Table 84. MicroPort Group Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. MicroPort Group Atrial Septal Defect (ASD) Occluder Product Offerings

Table 86. MicroPort Group Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Atrial Septal Defect (ASD) Occluder Downstream Customers

Table 90. Atrial Septal Defect (ASD) Occluder Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Atrial Septal Defect (ASD) Occluder Product Picture

Figure 2. Global Atrial Septal Defect (ASD) Occluder Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Atrial Septal Defect (ASD) Occluder Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Atrial Septal Defect (ASD) Occluder Sales Volume (2020-2031) & (K Units)

Figure 5. Global Atrial Septal Defect (ASD) Occluder Sales Price (2020-2031) & (US$/Unit)

Figure 6. Atrial Septal Defect (ASD) Occluder Report Years Considered

Figure 7. Global Atrial Septal Defect (ASD) Occluder Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Atrial Septal Defect (ASD) Occluder Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Atrial Septal Defect (ASD) Occluder Revenue in 2024

Figure 10. Atrial Septal Defect (ASD) Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 16-32 mm Type Picture

Figure 12. 34-50 mm Type Picture

Figure 13. Global Atrial Septal Defect (ASD) Occluder Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Atrial Septal Defect (ASD) Occluder Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 16. Global Atrial Septal Defect (ASD) Occluder Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Atrial Septal Defect (ASD) Occluder Price by Type (2020-2031) & (US$/Unit)

Figure 18. Product Picture of Children

Figure 19. Product Picture of Adult

Figure 20. Global Atrial Septal Defect (ASD) Occluder Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Atrial Septal Defect (ASD) Occluder Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Atrial Septal Defect (ASD) Occluder Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 23. Global Atrial Septal Defect (ASD) Occluder Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Atrial Septal Defect (ASD) Occluder Price by Application (2020-2031) & (US$/Unit)

Figure 25. North America Atrial Septal Defect (ASD) Occluder Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Atrial Septal Defect (ASD) Occluder Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Atrial Septal Defect (ASD) Occluder Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Atrial Septal Defect (ASD) Occluder Sales Volume (%), (2020-2031)

Figure 37. United States Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 43. China Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 45. China Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 55. India Atrial Septal Defect (ASD) Occluder Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Atrial Septal Defect (ASD) Occluder Sales Value by Type (%), 2024 VS 2031

Figure 57. India Atrial Septal Defect (ASD) Occluder Sales Value by Application (%), 2024 VS 2031

Figure 58. Atrial Septal Defect (ASD) Occluder Industrial Chain

Figure 59. Atrial Septal Defect (ASD) Occluder Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Atrial Septal Defect (ASD) Occluder market? zhanKai

The top companies in the global Atrial Septal Defect (ASD) Occluder market are Gore Medical、Abbott、Lepu Medical.

Related Reports

Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026
The global Atrial Septal Defect (ASD) Occluder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Atrial Septal Defect (ASD) Occluder market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 79
USD 4250.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 138
USD 4900.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2025
The global market for Atrial Septal Defect (ASD) Occluder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Insights, Forecast to 2030
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published Date: 2024-04-13
Pages: 109
USD 4900.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2024
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published Date: 2024-02-21
Pages: 88
USD 2900.00
(Single User License)
Atrial Septal Defect (ASD) Occluder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-09
Pages: 97
USD 3950.00
(Single User License)

Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 128
USD 3950.00 (Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026
The global Atrial Septal Defect (ASD) Occluder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 117
USD 2900.00 (Single User License)
Global Atrial Septal Defect (ASD) Occluder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Atrial Septal Defect (ASD) Occluder market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 79
USD 4250.00 (Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 138
USD 4900.00 (Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2025
The global market for Atrial Septal Defect (ASD) Occluder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 80
USD 2900.00 (Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Insights, Forecast to 2030
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published: 2024-04-13
Pages: 109
USD 4900.00 (Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2024
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published: 2024-02-21
Pages: 88
USD 2900.00 (Single User License)
Atrial Septal Defect (ASD) Occluder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-09
Pages: 97
USD 3950.00 (Single User License)